Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
以安慰剂对照,中央随机、双盲、多中心方法评价*滴丸治疗晚期非小细胞肺癌(气虚证)有效性及安全性研究
[Translation] A placebo-controlled, centrally randomized, double-blind, multicenter study to evaluate the efficacy and safety of * dripping pills in the treatment of advanced non-small cell lung cancer (Qi deficiency syndrome)
初步评价人参次苷H滴丸治疗晚期非小细胞肺癌的有效性和安全性,并进行剂量探索
[Translation] To preliminarily evaluate the efficacy and safety of ginsenoside H pills in the treatment of advanced non-small cell lung cancer and conduct dose exploration
以安慰剂为对照评价病毒无忧软胶囊治疗普通感冒(风热证)有效性和安全性的随机、双盲、平行对照临床研究
[Translation] A randomized, double-blind, parallel controlled clinical study to evaluate the efficacy and safety of Virus Wuyou soft capsules in the treatment of common cold (wind-heat syndrome) with placebo as control
以安慰剂为对照,评价病毒无忧软胶囊缩短普通感冒病程/热程、改善普通感冒症状、即时退热、改善感冒风热证的疗效;及其安全性及不良反应。
[Translation] Using placebo as a control, evaluate the efficacy of Virus Worry-Free Soft Capsules in shortening the course of common cold/fever, improving common cold symptoms, reducing fever immediately, and improving wind-heat syndrome of cold; as well as its safety and adverse reactions.
红花滴丸治疗冠心病心绞痛(心血瘀阻证)的安全性及有效性随机、双盲、安慰剂平行对照、多中心Ⅲ期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial on the safety and efficacy of Honghua dripping pills in the treatment of angina pectoris (cardiac blood stasis syndrome) caused by coronary heart disease
对红花滴丸治疗冠心病心绞痛(心血瘀阻证)有效性及安全性进一步评价。
[Translation] To further evaluate the effectiveness and safety of Honghua Drop Pills in treating angina pectoris (cardiac blood stasis syndrome) caused by coronary heart disease.
100 Clinical Results associated with Shandong Luye Natural Drug Research & Development Co., Ltd.
0 Patents (Medical) associated with Shandong Luye Natural Drug Research & Development Co., Ltd.
100 Deals associated with Shandong Luye Natural Drug Research & Development Co., Ltd.
100 Translational Medicine associated with Shandong Luye Natural Drug Research & Development Co., Ltd.